Sector: Pharmaceuticals & Biotechnology
|Small Cap
Accretion Pharmaceuticals Ltd.
₹137.70
₹137.70
₹142.25
₹53.80
₹145.85
Markets Today
Historical Performance
Indicator | Dec 2024 |
|---|---|
| Total Revenue | 17.10 |
| Operating Expense | 12.70 |
| Operating Profit | 4.40 |
| Depreciation | 0.21 |
| Interest | 0.37 |
| Tax | 1.12 |
| Net Profit | 2.77 |
₹137.70
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoter | 73.5 | 73.5 | 73.5 | 73.5 |
| FII | 2.2 | 1.2 | 0 | 0 |
| DII | 0.1 | 0 | 0 | 0 |
| Public | 24.2 | 25.3 | 26.5 | 26.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 12 K | 16.8 K | 71.43% |
| Week | 34.08 K | 38.4 K | 88.75% |
| 1 Month | 34.46 K | 38.34 K | 89.87% |
| 6 Month | 21.39 K | 24.2 K | 88.40% |
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹118.15 | ₹554.90 | ₹6.34 | ₹108.25 | ₹132.99 | ₹14.04 |
| % Change | N/A | 1.78% | -0.78% | -3.35% | -0.37% | 0.43% |
| Revenue TTM (₹ Cr) | - | - | ₹83.60 | - | ₹287.68 | ₹176.50 |
| Net Profit TTM (₹ Cr) | - | - | ₹-34.95 | - | ₹14.88 | ₹27.81 |
| PE TTM | 58.50 | - | -1.50 | 13.10 | 34.80 | 26.70 |
| 1 Year Return | -11.87 | 39.08 | 539 | -12.5 | 5.94 | 53.63 |
| ROCE | - | 3.56 | -5.63 | - | - | 17.36 |
Medistep Healthcare Ltd.
₹ 19.55
+0.00%
Influx Healthtech Ltd.
₹ 232.60
-2.68%
Medicamen Organics Ltd.
₹ 21.00
+0.00%
Amrutanjan Health Care Ltd.
₹ 552.00
-0.01%
Senores Pharmaceuticals Ltd.
₹ 1025.80
-0.86%
Innova Captab Ltd.
₹ 890.90
+2.70%
Valiant Laboratories Ltd.
₹ 72.90
-0.34%
Sigachi Industries Ltd.
₹ 21.20
-1.26%
Windlas Biotech Ltd.
₹ 815.00
+0.10%
Vineet Laboratories Ltd.
₹ 34.90
+0.37%
Solara Active Pharma Sciences Ltd.
₹ 538.25
+0.64%
Zim Laboratories Ltd.
₹ 108.50
+3.22%
Medico Remedies Ltd.
₹ 44.17
-2.97%
Dishman Carbogen Amcis Ltd.
₹ 186.58
-1.74%
Lasa Supergenerics Ltd.
₹ 7.69
-2.78%
Advanced Enzyme Technologies Ltd.
₹ 368.50
+0.40%
Bajaj Healthcare Ltd.
₹ 290.60
-0.99%
Ortin Global Ltd.
₹ 19.80
+9.33%
Brooks Laboratories Ltd.
₹ 68.00
+3.53%
RPG Life Sciences Ltd.
₹ 2115.00
-2.16%
Bafna Pharmaceuticals Ltd.
₹ 193.97
+10.00%
Alpa Laboratories Ltd.
₹ 68.75
-0.25%
SMS Pharmaceuticals Ltd.
₹ 373.50
+1.19%
Nectar Lifesciences Ltd.
₹ 11.74
-2.00%
By signing up I certify terms, conditions & privacy policy